I am Director, Patent Counsel at PTC Therapeutics where I am responsible for the IP development of early stage gene therapy projects. Drawing on an accomplished record both in postgraduate academic research and as inhouse counsel, Dr. Southgate advises PTC scientists and Business Development on the identification of potential IP with the requisite freedom-to-operate for commercial development as well as the preparation and prosecution of foundational patent applications. Dr. Southgate obtained his Ph.D. in molecular biology at the University of Zürich, Switzerland and a JD from the Washington College of Law, American University in DC.